BSX
$69.48-0.41 (-0.59%)
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates in two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and tre...
Recent News
Is Boston Scientific (BSX) Still Attractive After Its Recent Share Price Pullback?
If you are wondering whether Boston Scientific's current share price still reflects its long term potential, the recent moves in the stock give you plenty to think about. The shares last closed at US$69.48, with returns of 0.5% over 7 days, a 6.8% decline over 30 days, a 26.6% decline year to date, and a 31.0% decline over 1 year, set against gains of 44.1% over 3 years and 81.8% over 5 years. These mixed returns have kept attention on how the market is weighing Boston Scientific's growth...
Truist Cuts PT on Boston Scientific Corporation (BSX) to $92 From $95 – Here’s Why
Boston Scientific Corporation (NYSE:BSX) is one of the best long term stocks to invest in according to billionaires. Truist cut the price target on Boston Scientific Corporation (NYSE:BSX) to $92 from $95 on March 18, reiterating a Buy rating on the shares. The rating update came ahead of the company’s CHAMPION-AF readout, with the firm […]
Jim Cramer on Boston Scientific: “This Stock Was One of the Greatest Performers, It’s Not Anymore”
Boston Scientific Corporation (NYSE:BSX) is one of the stocks mentioned during the show, as we cover everything Jim Cramer said about the market. Answering a caller’s query about the company, Cramer said: You know, I have to tell you, I’ve been blown away… [by] how badly that stock’s performing. The competition got much more severe […]
Sector Update: Health Care Stocks Softer Late Afternoon
Health care stocks were softer late Thursday afternoon, with the NYSE Health Care Index decreasing 0
Market Chatter: Boston Scientific Amends Recall of Accolade Pacemakers, Affected Population Now 1.6 Million
Boston Scientific (BSX) amended the recall of its Accolade pacemakers again, updating the software f